Titan Medical Engages Shareholders with Upcoming Q&A Webcast
Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is preparing for an informative session designed specifically for its valued shareholders. This upcoming webcast, scheduled for a Thursday evening, will provide a platform for meaningful discussions regarding the company's strategic direction.
Webcast Details for Shareholders
The management team at Titan will conduct a Q&A session on a designated Thursday at 5:00 PM ET. This interactive event comes after the filing and mailing of the management information circular, which was previously announced. Joining the session will be Paul Cataford, Titan's Interim President and CEO, along with Chien Huang, the Chief Financial Officer, both of whom will share valuable insights during the discussion.
How to Participate
Shareholders are encouraged to take an active role by submitting their questions prior to the event. Inquiries can be sent to investors@titanmedicalinc.com. To ensure that all concerns are addressed during the Q&A, questions must be submitted by a specified deadline.
Accessing the Live Webcast
A link to join the live audio webcast will be made available in the “Investor Relations” section of Titan's official website. This approach promotes transparency, allowing shareholders and interested individuals to stay informed about the company's developments conveniently.
Introducing Titan Medical Inc.
Titan Medical Inc., incorporated under Ontario's Business Corporations Act, is a leader in medical technology. With its headquarters in Toronto, the company specializes in robotic-assisted surgery (RAS) and holds a comprehensive patent portfolio aimed at transforming surgical practices. Their advancements in medical robotics show significant promise for improving surgical outcomes through innovative techniques, including single access point procedures.
Commitment to Future Opportunities
As Titan seeks to explore new avenues for growth, the company is committed to evaluating opportunities to license its intellectual assets. This proactive strategy ensures that Titan remains competitive in the ever-evolving medical landscape.
Frequently Asked Questions
What is the purpose of Titan's upcoming Q&A session?
The upcoming Q&A session is designed to engage shareholders by providing updates on the company's strategic direction, operations, and opportunities for interaction with management.
Who from Titan will attend the Q&A session?
Paul Cataford, the Interim President and CEO, and Chien Huang, the Chief Financial Officer, will represent Titan during the Q&A session, offering insights and responding to shareholder inquiries.
How can shareholders submit questions for the Q&A?
Shareholders can send their questions in advance by emailing investors@titanmedicalinc.com. There is a deadline for submitting questions before the session.
Where can I find the link to the live webcast?
The link to the live audio webcast will be posted in the “Investor Relations” section of Titan’s official website shortly before the event begins.
What are Titan Medical’s core focus areas?
Titan Medical is dedicated to advancing robotic-assisted surgical technologies, particularly through innovations aimed at enhancing surgical outcomes for patients.
